PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Public ClinicalTrials.gov record NCT01212770. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis and a Qualifying Psoriasis Lesion
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether apremilast is safe and effective in the treatment of patients with psoriatic arthritis and a qualifying psoriasis lesion. Apremilast is proposed to improve signs and symptoms of psoriatic arthritis (tender and swollen joints, pain, physical function) in treated patients.
Study identification
- NCT ID
- NCT01212770
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 505 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2010 (Actual)
- Primary completion
- Aug 21, 2012 (Actual)
- Completion
- Feb 9, 2017 (Actual)
- Last update posted
- May 6, 2020
2010 – 2017
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Elite Clinical Studies, LLC | Phoenix | Arizona | 85018 | — |
| Catalina Pointe Clinical Research Incorporated | Tucson | Arizona | 85704 | — |
| Bakersfield Dermatology and Skin Cancer Medical Group | Bakersfield | California | 93309 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Desert Medical Advances | Palm Desert | California | 92260 | — |
| Joao Nascimento, MD | Bridgeport | Connecticut | 6606 | — |
| In Vivo Clinical Research | Doral | Florida | 33166 | — |
| Suncoast Clinical Research | New Port Richey | Florida | 34652 | — |
| Rheumatology Associates of Long Island | Orlando | Florida | 32806 | — |
| Advent Clinical Research | Pinellas Park | Florida | 33781 | — |
| Rockford Orthopedic Associates, LLC | Rockford | Illinois | 61107 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46256 | — |
| DermResearch, PLLC | Louisville | Kentucky | 40217 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01605 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| STAT Research, Inc. | Dayton | Ohio | 45417 | — |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | — |
| Austin Dermatology Associates | Austin | Texas | 78705 | — |
| Austin Regional Clinic | Austin | Texas | 78731 | — |
| Center for Clinical Studies | Houston | Texas | 77065 | — |
| Houston Medical Research | Houston | Texas | 77090 | — |
| Texas Research Center | Sugar Land | Texas | 77479 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01212770, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2020 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01212770 live on ClinicalTrials.gov.